Retinitis pigmentosa: recent advances and future directions in diagnosis and management

Current Opinion in Pediatrics
Abigail Fahim

Abstract

Retinitis pigmentosa is a group of genetically diverse inherited blinding disorders for which there are no treatments. Owing to recent advances in imaging technology, DNA sequencing, gene therapy, and stem cell biology, clinical trials have multiplied and the landscape is rapidly changing. This review provides a relevant and timely update of current trends and future directions for the diagnosis and management of this disease. This review will highlight the use of retinal imaging to measure progression of disease, next-generation sequencing for genetic diagnosis, the use of electronic retinal implants as well as noninvasive digital low-vision aids, and the current state of preclinical and clinical research with gene therapy and cell-based therapies. Retinitis pigmentosa has historically been an untreatable condition. Recent advances have allowed for limited improvement in visual outcomes for select patients. Retinal degenerative disease is on the cutting edge of regenerative medicine. Gene therapy and stem cell therapeutic strategies are currently under investigation and are expected to radically impact management of inherited retinal disease in the coming years. VIDEO ABSTRACT: http://links.lww.com/MOP/A33.

References

Jun 1, 1993·Archives of Ophthalmology·E L BersonW Willett
Oct 9, 1996·JAMA : the Journal of the American Medical Association·J M SeddonS E Hankinson
Sep 15, 2004·Archives of Ophthalmology·Eliot L BersonErnst J Schaefer
Feb 14, 2007·Archives of Ophthalmology·Stephen P DaigerLori S Sullivan
Apr 14, 2010·Archives of Ophthalmology·Eliot L BersonErnst J Schaefer
Nov 15, 2012·Investigative Ophthalmology & Visual Science·Kari BranhamAnand Swaroop
May 25, 2013·Clinical Genetics·S P DaigerS J Bowne
Apr 9, 2014·IEEE Transactions on Bio-medical Engineering·James D Weiland, Mark S Humayun
May 6, 2015·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Oct 17, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Nataša Savić, Gerald Schwank
Jul 14, 2016·Scientific Reports·Alona O Barnea-CramerRobert Lanza
Dec 4, 2016·The British Journal of Ophthalmology·S StrongM Michaelides
Jan 4, 2017·American Journal of Ophthalmology·Joshua R EhrlichSayoko E Moroi
Jan 5, 2017·The Korean Journal of Internal Medicine·Eun Ji KimJi Hyeon Ju
May 27, 2017·Molecular Genetics & Genomic Medicine·Deirdre WeymannDean A Regier
Oct 11, 2017·Survey of Ophthalmology·Malini BakthavatchalamMarten E Brelen
Nov 17, 2017·The British Journal of Ophthalmology·Michalis GeorgiouMichel Michaelides
Jun 6, 2018·Journal of Law and the Biosciences·Lily Hoffman-Andrews

❮ Previous
Next ❯

Citations

Apr 29, 2020·Investigative Ophthalmology & Visual Science·Katharina G FooteJacque L Duncan
May 28, 2020·Micromachines·Shinyong ShimSung June Kim
Sep 29, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Qin WangFeng Pan
Jan 16, 2021·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Minfang ZhangZheng Qin Yin
Feb 3, 2021·European Journal of Ophthalmology·Ilkay Kilic MuftuogluJay Chhablani
Apr 10, 2020·Progress in Retinal and Eye Research·Marina S GorbatyukOleg S Gorbatyuk
Mar 11, 2021·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Fleur O'HareLauren N Ayton
Mar 10, 2021·Clinical & Experimental Ophthalmology·Michalis GeorgiouMichel Michaelides
Jul 1, 2021·ClinicoEconomics and Outcomes Research : CEOR·Marie ChiversJittrakul Leartsakulpanitch
May 28, 2021·Ear and Hearing·Eric NisenbaumXuezhong Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Investigative Ophthalmology & Visual Science
Robert Wojciechowski
Australian and New Zealand Journal of Ophthalmology
A C Bird
Bulletin de la Société belge d'ophtalmologie
G Kleefeld
© 2022 Meta ULC. All rights reserved